baber/WOPTO huggingface dataset:
Patent AU-2003246875-A1 (AU)
Title: Packaging material with cavity, in particular for vegetable material
Inventor: BEAUDOUIN JEAN-MICHEL CLAUDE E
IPC: B65D65/02
Filed: 2003-04-29
Abstract: The invention concerns a packaging material comprising two layers delimiting between them a cavity. A substance capable of retaining gas therein is housed in the cavity and one of the layers is permeable to gas ethylene and impermeable to water vapour.
Patent AU-2003248322-A1 (AU)
Title: Machine and method for bunching plant stems
Inventor: VIS ANDREAS GERARDUS
IPC: B65B13/18
Filed: 2003-09-24
Abstract: The machine has a supply mechanism having a pair of rollers (10). A receiving mechanism has a flexible band (14) for receiving plant stems and when the roller rotates, the stems are carried along between the rollers. A gripper (11) is movable relative to the rollers and has a pair of fingers (12) to grip. A part of the band is tensioned between the fingers, where the stems in gripper are moved away from rollers. The rollers are arranged rotatably about mutually parallel rotary shafts, thus the surfaces of revolution of the rollers substantially touch each other. Independent claims are also included for the following: (a) a gripper for a machine for bunching plant stem (b) a method for bunching plant stem.
Patent AU-2003252994-A1 (AU)
Title: Microencapsulated agrochemical composition
Inventor: BELL GORDON ALASTAIR
IPC: A01N47/30
Filed: 2003-08-12
Abstract: A microencapsulated agrochemical composition comprises an aqueous dispersion of microcapsules containing (a) an agrochemical (b) a water-insoluble, bioperformance enhancing adjuvant for said agrochemical wherein said adjuvant has little or no surfactant properties and (c) a water-immiscible solvent in which both the agrochemical and adjuvant are soluble.
Patent AU-2003262869-A1 (AU)
Title: Metal complexes of alpha amino dicarboxylic acids
Inventor: ABDEL-MONEM MAHMOUD M
IPC: A23K1/175
Filed: 2003-08-25
Abstract: Neutral alpha amino diacid complexes of trace minerals and their use for animal nutrition.
Patent AU-2003264051-A1 (AU)
Title: Method and apparatus for a client connection manager
Inventor: SCHWARTZ ELLIOT
IPC: H04L29/08
Filed: 2003-08-13
Abstract: A method and apparatus for a connection manager have been disclosed. By providing for persistent connections with clients, the connection manager allows for servers to communicate with clients, which would otherwise be inaccessible.
Patent AU-2003268605-A1 (AU)
Title: Cationic alkyd polyesters for medical applications
Inventor: NATHAN ARUNA
IPC: A61L27/58
Filed: 2003-12-11
Abstract: The present invention is directed to medical devices or pharmaceutical compositions, each containing a synthetic, biodegradable, biocompatible polymer that is the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a cationic polyol.
Patent AU-2003279541-A1 (AU)
Title: Process for the preparation 3,5-bis(trifluoromethyl)benzylalcohol
Inventor: NARDELLO ALESSANDRO
IPC: C07C17/16
Filed: 2003-10-13
Abstract: The present invention concerns a process for preparing 3,5bis(trifluoromethyl)benzylalcohol by formylation in a solvent of an appropriate organo-magnesium derivative with solid paraformaldehyde and optionally its conversion into a 3,5-bis(trifluoromethyl)benzyl halide.
Patent AU-2003303118-A1 (AU)
Title: A valve device having two membranes for a drinking container
Inventor: NAESJE KJETIL
IPC: A47G19/22
Filed: 2003-12-09
Abstract: An underpressure-activated valve device for a drinking container (32). The device consists of an outer membrane (2) and an inner membrane (4) that are placed at an axial distance from one another, and their peripheral attachment areas are pressure-sealingly interconnected, causing a reference pressure chamber (6) having at least one vent (8) to an ambient pressure P1 to exist between the membranes (2, 4). One membrane (2, 4) is fixedly connected to a flow pipe (10), and the other membrane (4, 2) is provided with a membrane opening (12) within which the pipe (10) is movably arranged. The membrane opening (12) is associated with a primary sealing body (18) for sealing against fluid flow via the pipe (10), and with a secondary sealing body (16) for sealing between the chamber (6) and an internal pressure P3 in the container (32). Both sealing bodies (16, 18) are placed in pressure-sealing contact with the pipe (10) when the valve device is in an inactive position of rest, while at least the primary sealing body (18) is placed in an open position when the valve device is in an active position.
Patent WO-2004077056-A1 (WO)
Title: Methode de diagnostic et agents utilises dans cette methode
Inventor: DOYLE IAN R
IPC: G01N33/68
Filed: 2004-02-27
Abstract: L'invention concerne, de manière générale, une méthode de diagnostic, de prédiction ou de gestion du développement ou de l'état d'avancement d'une insuffisance cardiaque chez un mammifère et, plus particulièrement, une méthode de diagnostic, de prévision ou de gestion du développement ou de l'état d'avancement d'une insuffisance cardiaque congestive chez un mammifère. Cette invention étudie une méthode de détection de l'insuffisance cardiaque par criblage de la présence systémique de protéines tensioactives pulmonaires chez un sujet. L'invention concerne aussi une méthode de diagnostic ou de gestion des conditions associées à l'apparition de l'insuffisance cardiaque ou caractérisées par celle-ci, notamment l'insuffisance cardiaque congestive. Elle concerne enfin des agents de diagnostic utiles dans la détection d'une ou plusieurs protéines tensioactives.
Patent AU-2004215030-A1 (AU)
Title: Method for selecting a candidate drug compound
Inventor: TIMMERMAN PETER
IPC: G01N33/543
Filed: 2004-02-26
Abstract: The invention relates to the field of candidate drug testing and drug development. The invention provides a method for selecting a candidate drug compound from among a library of compounds wherein binding of a target molecule is determined with said candidate compound bound to a solid support and also is determined with said candidate compound not bound to a solid support said method comprising selecting said candidate compound from among compounds composed of an invariant scaffold molecule to which a variant potential binding site molecule is linked. Furthermore, the invention relates to methods for attaching molecules to a scaffold. In particular, the invention relates to the synthesis of discontinuous or conformational binding sites or epitopes corresponding to or interacting with a binding molecule, in particular in relation to protein-protein or protein-ligand interactions.
Patent AU-2004279294-A1 (AU)
Title: Activated vapor treatment for neutralizing warfare agents
Inventor: MCVEY IAIN F
IPC: A61L2/20
Filed: 2004-04-23
Abstract: Hydrogen peroxide is vaporized (20) and mixed (30) with ammonia gas in a ratio between 1:1 and 1:0.0001. The peroxide and ammonia vapor mixture are conveyed to a treatment area (10) to neutralize V-type, H-type, or G-type chemical agents, pathogens, biotoxins, spores, prions, and the lip-,e. The ammonia provides the primary deactivating agent for G-type agents with the peroxide acting as an accelerator. The peroxide acts as the primary agent for deactivating V-type and H-type agents, pathogens, biotoxins, spores, and prions. The ammonia acts as an accelerator in at least some of these peroxide deactivation reactions.
Patent WO-2005075186-A1 (WO)
Inventor: NASARCZYK ANDREW
IPC: F16L11/00
Filed: 2005-02-09
Abstract: A fabric (1) including a film (2) of tubular formation, and a material layer (3) applied to at least one side (5) of the tubular film (2) to provide a laminated fabric with applicable characteristics. A method of manufacturing the fabric (1), and tubes formed from the fabric (1) are also disclosed.
Patent WO-2005091247-A1 (WO)
Inventor: HALLAM ADRIAN
IPC: G09B5/14
Filed: 2005-03-22
Abstract: A method of teaching uses a computer network. The method provides an electronic medium such as a diary for entry of a submission by a student. The submission is accepted over the computer network and amendments made to the received submission. The amended submission is sent over the computer network back to the student.
Patent WO-2005105536-A1 (WO)
Title: Systeme sur reseau de controle de l'integrite d'un train
Inventor: SEARLE DONALD STEPHEN
IPC: B61L15/00
Filed: 2005-05-03
Abstract: Un système sur réseau de contrôle de l'intégrité d'un train comprend des unités pour bogies, qui contrôlent des paramètres critiques relatifs à l'états de composants des bogies et du rail sur lequel ils se déplacent, un serveur embarqué qui commande les unités pour bogies et un réseau sans fil qui permet la communication entre le serveur et les unités de bogie. Chaque unité pour bogie est alimentée par un générateur électrique qui utilise la rotation des roues en bogie et possède un processeur qui compare les paramètres critiques aux normes définies afin de produire des alarmes destinées au conducteur du train. Le réseau sans fil utilise la commutation de rôle dans la bande de base de maître/esclave, possède des noeuds qui acheminent des données en temps quasi réel jusqu'au serveur et utilise des modes de saut de fréquence.
Patent AU-2005211965-A1 (AU)
Title: Protease inhibitors for the treatment of digestive pathologies
Inventor: BUENO LIONEL
IPC: A61K38/55
Filed: 2005-01-18
Abstract: Use of at least one protease inhibitor (I) to prepare a composition for preventative or curative treatment of intestinal disorders characterized by hyperalgesia. An independent claim is also included for a pharmaceutical product (A) containing at least one (I) and at least one other agent (II), i.e. an anticholinergic, prokinetic or antidiarrhea agent; laxative; modifier of motility or of viscero-sensitivity, for combined use, separately or sequentially. ACTIVITY : Analgesic; Antiinflammatory. MECHANISM OF ACTION : (I) control (reduce) the paracellular permeability of the intestinal epithelium, by controlling the light junctions, and associated pain. Proteases, produced by bacteria in the colon, activate receptors in the membrane of epithelial cells that modulate opening of these junctions, where opening is responsible for hyperalgesia. Mice were perfused, through the colon, with 250 mu l/hour of a solution of protease inhibitors, labeled with 51-chromium-EDTA. After 5 hours, the colons were removed and the amount of bound radioactivity measured as an indicator of paracellular permeability. For a control, retention of radioactivity was about 2.1%; compare about 1.1% following perfusion with a cocktail of protease inhibitors (or with serine protease or matrix metalloprotease inhibitors).
Patent WO-2006079168-A1 (WO)
Inventor: LING WILLIAM PUI
IPC: G02F1/11
Filed: 2006-01-25
Abstract: A photoelastic modulator (PEM) has two parts (11, 13) of the same or dissimilar cross sections, joined together to form an abrupt junction (16). A transducer, for which the natural oscillation is at the half acoustic wavelength mode, excites a longitudinal standing wave of high purity in the PEM. A feedback system is used to achieve stable phase synchronisation of multiple PEMs working at the same oscillation frequency, where the outputs of an amplitude and phase sensor for one PEM is used to correct phase variations of other PEMs and to compensate optical retardation errors.
Patent WO-2007062449-A1 (WO)
Title: Turlutte de peche a porte-leurre
Inventor: CALDERWOOD JOHN MORTON
IPC: A01K83/06
Filed: 2006-10-25
Abstract: L'invention concerne une turlutte de pêche capable de porter un leurre, la turlutte comprenant un arbre primaire doté d'une extrémité pour la fixation d'une ligne de pêche et d'une extrémité libre fourchue, l'extrémité libre soutenant des ensembles crochet opposés de telle sorte que chaque ensemble crochet soit décalé par rapport à l'arbre primaire. L'arbre primaire est de préférence suffisamment long pour qu'un leurre puisse être embroché sur la turlutte et ainsi maintenir le leurre globalement en son centre, l'extrémité de fixation faisant saillie du leurre par sa tête ou à proximité de celle-ci et l'extrémité libre fourchue (ainsi que les ensembles crochet opposés) faisant saillie du leurre par sa queue ou à proximité de cette dernière.
Patent WO-2007062483-A1 (WO)
Title: Formulation visant à augmenter le taux de grossesse
Inventor: BELL ALAN RICHARD
IPC: A61K38/24
Filed: 2006-12-01
Abstract: La présente invention concerne une formulation stable pour contrôler l'oestrus chez un sujet. La formulation comprend de l'hormone de libération des gonadotrophines ou un sel ou analogue acceptable de celle-ci, de la progestérone ou un analogue de celle-ci, et un véhicule acceptable.
Patent AU-2006227555-A1 (AU)
Title: Isoflavonoid dimers
Inventor: KUMAR NARESH
IPC: C07D493/04
Filed: 2006-03-24
Abstract: Anti-inflammatory modalities are described with reference to select isoflavonoid compounds, compositions containing same and the use of said compounds and/or compositions in treatment, particularly for the treatment of inflammatory diseases and related conditions.
Patent AU-2006291867-A1 (AU)
Title: Vehicle for disabled individuals
Inventor: ELIZOV ALEXANDER
IPC: B62K5/025
Filed: 2006-01-18
Abstract: Described is a vehicle for handicapped persons, thus persons who are limited in their mobility. They may be provided with a seat, but may also be used when standing. The vehicle includes a steerable front wheel and two rear wheels. The rear wheels are in each case individually held in a wheel suspension on a frame. Furthermore, a separately controllable steering drive is present for each rear wheel.
Patent WO-2008043126-A1 (WO)
Title: Dispositif de fixation pour attacher un matériau flexible à une structure
Inventor: BOSTON SAXON
IPC: E04F13/21
Filed: 2007-08-27
Abstract: L'invention concerne un système de fixation (60) pour attacher un matériau en bande flexible, tel qu'un tissu à stores, à une structure. Ce système comporte un élément de fixation allongé (62) présentant une partie sensiblement cylindrique (64). La partie sensiblement cylindrique (64) est montée d'une façon espacée par rapport à la surface de la structure pour faciliter la fixation du matériau en bande flexible à l'élément de fixation. L'espace entre la partie sensiblement cylindrique (64) et la surface de la structure est rempli par une jupe (72). Un élément de retenue (74) est positionné sur la partie sensiblement cylindrique (64) pour attacher le matériau en bande flexible sur l'élément de fixation (62). Le système de fixation permet de remplacer facilement un tissu de stores endommagé ou usé, ainsi que de réutiliser le système de fixation existant pour le positionnement d'un nouveau tissu à stores.
Patent AU-2007224669-A1 (AU)
Title: Pegylated mutated clostridium botulinum toxin
Inventor: FREVERT JURGEN
IPC: C07K14/33
Filed: 2007-03-15
Abstract: Modified botulinum toxin (BoNT) which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end. Modified botulinum toxin (BoNT), which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end, with a structure of (-(Cy) n-(tag) m-(X) l). Cy : cysteine residue, where at least one of the cysteine residues in the chain extension is coupled to at least a chain polyethylene glycol; tag : any tag, preferably histidine tag or streptavidin tag; X : any naturally occurring amino acid; n : 1-50; m : 0 or 1; and l : 0-50. Independent claims are included for: (1) a composition for human and/or veterinary medicine comprising the modified botulinum toxin; (2) a nucleic acid which codes for the modified botulinum toxin; (3) a vector comprising the nucleic acid; and (4) a host cell comprising the vector. ACTIVITY : Muscular-Gen; Neuroprotective; Muscle-Relaxant; Antiinflammatory; Gastrointestinal-Gen; Inotropic; Dermatological. MECHANISM OF ACTION : None given.
Patent AU-2007359103-A1 (AU)
Title: Method and system for completing a zone related call
Inventor: BARBOSA CAMILO ERNESTO MORALES
IPC: H04W4/029
Filed: 2007-09-20
Abstract: A method and system, for completing a call to a mobile subscriber having one or more zones defined, where the calling party is presented options for call completion based on the distance and direction of the called mobile subscriber in relation to his zones and presence inside a perimeter around his zone. The call completion comprising; call back, notification by SMS or notification by voice message on entry or exit of the area enclosed by the perimeter, or connect with additional charges for the calling party.
Patent AU-2008203369-A1 (AU)
Title: Antibody against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood
Inventor: SMITH MARIA LEIA
IPC: C12N15/06
Filed: 2008-07-28
Abstract: Disclosed is an antibody against a secreted form of GPC3 capable of detecting a secreted form of glypican 3 (GPC3) in a test sample. It is possible to determine whether a subject suffers from cancer, in particular hepatoma. 
Also disclosed is an antibody against GPC as well as a cell disrupting agent and an anti-cancer agent comprising the same, which can disrupt cells, in particular cancer cells.
Patent AU-2008203450-A1 (AU)
Title: Sintering ultrahigh molecular weight polyethylene
Inventor: VISJAGER JEROEN
IPC: B29C67/04
Filed: 2008-08-01
Abstract: Methods of making ultrahigh molecular weight polyethylene (UMWPE) having increased strength and/or wear resistance, such as high yield strength, high tensile strength, high load strength, and/or high impact strength. Some embodiments include making UHMWPE having increased strength and/or wear resistance, such as that listed above, where the UHMWPE has co-monomers.
Patent AU-2008311101-A1 (AU)
Title: Centralized mobile access point acquisition
Inventor: BALASUBRAMANIAN SRINIVASAN
IPC: H04W48/18
Filed: 2008-10-03
Abstract: Providing for centralized access management to diverse types of mobile network access points is described herein. By way of example, network components can generate a system determination list (SDL) for a user terminal (UT) that is customized to access capabilities of the UT and/or current position of the UT. The SDL can be employed by the UT to determine which network access points to camp on, handoff to, or the like. The network components can include a network database that maintains UT subscriber and related home Femto cell information, or such information can be maintained at a network operator's home location register. In some aspects, the information can be obtained over the air from the UT or from a base station serving the UT.
Patent WO-2010025501-A1 (WO)
Inventor: VISSER DARREN
IPC: A63B69/18
Filed: 2009-09-01
Abstract: A snow sports apparatus (10) including: a hollow housing (12) having an internal generally cylindrical surface (12) and supported, with its axis having a major horizontal component, for rotation about said axis; and means (60) to provide on said internal generally cylindrical surface (30), a surface that, as the housing (12) is rotated, is relatively traversable downwardly on skis or a snowboard on the initial rising part (115) of the surface's travel.
Patent WO-2010060153-A1 (WO)
Title: Procédé et appareil de détermination des états de sommeil
Inventor: ABEYRATNE UDANTHA
IPC: A61B5/374
Filed: 2009-11-27
Abstract: L'invention porte sur un appareil de détection des états d'architecture de macro sommeil d'un sujet tels qu'un état de veille (WAKE), un sommeil à mouvements oculaires lents (NREM) et un sommeil à mouvements oculaires rapides (REM) à partir d'un électroencéphalogramme EEG d'un sujet. L'appareil comprend un ensemble de modules numériques de signaux d'EEG conçus de façon à convertir les signaux analogiques d'EEG en signaux numériques d'EEG. Un ensemble bispectral répond à l'ensemble de signaux numériques  d'EEG et convertit les signaux numériques d'EEG en signaux représentant des valeurs bispectrales correspondantes. L'ensemble de série temporelle bispectral, en communication électrique avec un côté de sortie de l'ensemble bispectral, génère au moins une série temporelle bispectrale pour une fréquence prédéterminée. Un ensemble d'architecture de macro sommeil (MSA) répond à l'ensemble de série temporelle bispectrale et est conçu de façon à générer un classement de signaux indiquant un classement de segments des signaux d'EEG dans des états de macro sommeil du sujet.
Patent AU-2009322913-A1 (AU)
Title: Composition for the use to treat Alzheimer' s Disease
Inventor: CURT HENDRIX
IPC: A61K31/353
Filed: 2009-06-03
Abstract: Formulations for the prevention and treatment of neurological diseases and cognitive deficiencies, i.e., Alzheimer's Disease (AD), Parkinson's Disease, amyotrophic lateral sclerosis, mild cognitive impairment and other types of dementia, comprise therapeutically effective amounts of curcumin, piperine, epigallocatechin-3-gallate (EGCG) and one or more of N-acetylcysteine, benfotiamine and alpha-lipoic acid. The combination addresses some or all of the pathways which can result in neurological deficiencies, degeneration and diseases.
Patent WO-2010144956-A1 (WO)
Title: Procédé pour l'augmentation de la stabilité d'une liqueur de procédé bayer
Inventor: LOAN MITCH
IPC: C01F7/0633
Filed: 2010-06-16
Abstract: L'invention concerne un procédé d'augmentation de la stabilité d'une liqueur de procédé Bayer, le procédé comportant la mise en contact d'une liqueur de procédé Bayer avec une quantité en ppm (partie par million) d'un composé contenant du calcium pour obtenir une concentration finale d'oxyde de calcium qui est suffisante pour supprimer ou réduire la précipitation des composés contenant de l'aluminium à partir de la liqueur de procédé Bayer.
Patent AU-2010222942-A1 (AU)
Title: Anti-CD40 antibodies and uses thereof
Inventor: BANCHEREAU JACQUES F
IPC: G01N33/68
Filed: 2010-03-05
Abstract: The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Patent AU-2010224477-A1 (AU)
Title: Toothbrush
Inventor: SIEGFRIED BAUERNFEIND
IPC: A46B9/04
Filed: 2010-03-15
Abstract: The invention is directed to a toothbrush head (4) with a bristle support (6) to which a plurality of preferably tuft-shaped cleaning elements (8) are affixed, said bristle support (6) including at least one movable rocker (10, 11) having a first end (13) attached to it on the side remote from a handpiece-side end of the toothbrush head (4) and having a free second end (14) which is on the side close to the handpiece-side end of the toothbrush head (4), said rocker (10, 11) carrying at least one row of cleaning elements (8). The invention relates in addition to a preferably manual toothbrush having such a toothbrush head (4). According to the invention, at least the cleaning elements (8) arranged on the rocker (10, 11) furthest from a longitudinal center plane (14) of the toothbrush head (4) have their free ends (14) inwardly tilted towards said longitudinal center plane (15) at an acute angle.
Patent AU-2010227245-A1 (AU)
Title: Fused pyrimidine-dione derivatives as TRPA1 modulators
Inventor: SUNDARLAL CHAUDHARI SACHIN
IPC: A61P13/00
Filed: 2010-03-17
Abstract: The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPAl (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPAl. Formula (I)